Randomized phase III trial of erlotinib vs. docetaxel in patients with advanced squamous cell non-small cell lung cancer (SqNSCLC) failing first line platinum based doublet chemotherapy stratified by VeriStrat Good vs VeriStrat Poor: The European Thoracic Oncology Platform (ETOP) EMPHASIS trial.

Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), ISSN 1527-7755

Volume 33, 15_suppl, 2015

DOI:10.1200/jco.2015.33.15_suppl.8049, Dimensions: pub.1113607148,



  1. (1) University Hospital of Lausanne, grid.8515.9
  2. (2) VU University Medical Center, grid.16872.3a
  3. (3) National and Kapodistrian University of Athens, grid.5216.0
  4. (4) Hospital Universitario 12 De Octubre, grid.144756.5
  5. (5) Hospital General Universitario de Alicante, grid.411086.a
  6. (6) Luzerner Kantonsspital, grid.413354.4
  7. (7) University Hospital Limerick, grid.415522.5
  8. (8) Hospital Universitario Severo Ochoa, grid.411361.0
  9. (9) Deventer Ziekenhuis, grid.413649.d
  10. (10) Institut Jules Bordet, grid.418119.4
  11. (11) Aarhus University Hospital, grid.154185.c, Central Denmark Region
  12. (12) Hospital Universitario Regional y Virgen de la Victoria Málaga, Málaga, Spain
  13. (13) Hospital Arnau de Vilanova, grid.413937.b
  14. (14) Mario Negri Institute for Pharmacological Research, grid.4527.4
  15. (15) Frontier Science Foundation-Hellas, grid.490781.3
  16. (16) European Thoracic Oncology Platform (ETOP) Coordinating Office, Bern, Switzerland
  17. (17) Medical University Vienna - General Hospital, Vienna, Austria
  18. (18) San Raffaele Hospital, grid.18887.3e
  19. (19) University Hospital of Zurich, grid.412004.3

Research Categories

Main Subject Area

Fields of Research

Links & Metrics

Dimensions Citation Indicators

Times Cited: 0

Field Citation Ratio (FCR): 0